Leerink Swann Downgrades Par Pharmaceutical (PRX) to Market Perform; Not Expecting Mylan (MYL) To Up The Ante
Tweet Send to a FriendGet Alerts PRX Hot Sheet
Price: $49.98 --0%
Rating Summary:
2 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 28 | New: 14
Rating Summary:
2 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 28 | New: 14
Trade PRX Now!
Leerink Swann downgraded Par Pharmaceutical (NYSE: PRX) from Outperform to Market Perform. Price target raised to $50.
Analyst, Jason M. Gerberry, said, "We believe investors should take profits following the announcement that PRX will be purchased by TPG, a private equity firm for $50/shr. PRX has to Aug. 24, 2012 to solicit superior proposals."
Gerberry notes that PRX would be a good fit for Mylan (NYSE: MYL), but he doesn't feel they (or any others) will bid more than $50/share.
For an analyst ratings summary and ratings history on Par Pharmaceutical click here. For more ratings news on Par Pharmaceutical click here.
Shares of Par Pharmaceutical closed at $36.58 yesterday, with a 52 week range of $24.85-$42.80.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Analyst, Jason M. Gerberry, said, "We believe investors should take profits following the announcement that PRX will be purchased by TPG, a private equity firm for $50/shr. PRX has to Aug. 24, 2012 to solicit superior proposals."
Gerberry notes that PRX would be a good fit for Mylan (NYSE: MYL), but he doesn't feel they (or any others) will bid more than $50/share.
For an analyst ratings summary and ratings history on Par Pharmaceutical click here. For more ratings news on Par Pharmaceutical click here.
Shares of Par Pharmaceutical closed at $36.58 yesterday, with a 52 week range of $24.85-$42.80.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Exane BNP Paribas Downgrades BlackBerry (BBRY) to Underperform; Analyst Says Profit 'Drying Up'
- UPDATE: Sprint (S) to Raise Offer for Clearwire (CLWR) - DJ
- Jefferies Downgrades First Republic Bank (FRC) to Hold
Create E-mail Alert Related Categories
Downgrades, Mergers and Acquisitions
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
